Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models.
Albaugh, P., Fan, Y., Mi, Y., Sun, F., Adrian, F., Li, N., Jia, Y., Sarkisova, Y., Kreusch, A., Hood, T., Lu, M., Liu, G., Huang, S., Liu, Z., Loren, J., Tuntland, T., Karanewsky, D.S., Seidel, H.M., Molteni, V.(2012) ACS Med Chem Lett 3: 140-145
- PubMed: 24900443 
- DOI: 10.1021/ml200261d
- Primary Citation of Related Structures:  
3V5Q - PubMed Abstract: 
Neurotrophins and their receptors (TRKs) play key roles in the development of the nervous system and the maintenance of the neural network. Accumulating evidence points to their role in malignant transformations, chemotaxis, metastasis, and survival signaling and may contribute to the pathogenesis of a variety of tumors of both neural and non-neural origin ...